*1.On a scale of 0-10 where 0 is not at all aware and 10 is very aware, how aware are you of the significance of peripheral retinal changes in determining the future development of GA and AMD centrally?(Required.)

0

1

2

3

4

5

6

7

8

9

10

0

1

2

3

4

5

6

7

8

9

10

2.How receptive are patients to discussions about potential macula changes and the impact on their eye health?

Very receptive, they actively engage and ask questions

Moderately receptive, they listen but may not necessarily grasp its importance

Not very receptive

*3.How often do you assess the far retinal periphery for early age-related changes in a patient over the age of 50? Please tick all that apply.(Required.)

Patients who present with any visual symptom

All patients over the age of 50

Patients with a history of AMD in the family

Patients with diabetes

Only patients who present with symptoms that could be related to macular changes

Patients who smoke

*4.What method do you use to view the far retinal periphery?(Required.)

Direct ophthalmoscopy through undilated pupils

Direct ophthalmoscopy through dilated pupils

Volk Lens through undilated pupils

Volk Lens through dilated pupils

Optos ultra-widefield retinal imaging device

Eidon Imaging systems

Zeiss imaging systems

Other (please specify)

5.Do you routinely use autofluorescent imaging in your clinical retinal assessment?

Yes

No - I don't have AF modality available to me

Sometimes

6.What are the main challenges you’ve experienced when explaining to patients the risks and potential vision loss associated with age-related macular degeneration? Please tick all that are relevant.

Lack of patient awareness of eye conditions which can result in vision loss

Fear of experiencing vision loss

Difficulty comprehending complex medical information

Other (please specify)

7.Do you routinely discuss health and lifestyle issues with your patients around diet, stopping smoking, obesity etc? Please tick all that are relevant.

Yes routinely with all at risk patients involving all risk areas

Yes but only with older patients

Yes but only with patients who smoke

No I don't discuss health and lifestyle issues with my patients

Other (please specify)

8.How do you support patients emotionally when discussing potential vision-threatening conditions such as age-related macular degeneration? Please tick all that are relevant.

I offer reassurance and emphasise the best lifestyle changes and next steps to help manage and prevent further deterioration

I provide resources for emotional support and encourage open discussions

I find it difficult addressing the emotional aspect and could use more guidance in this area

Emotional support should be provided by an ophthalmologist upon formal diagnosis of a vision-threatening condition